This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Androgen receptor | |
|---|---|
| Name | Androgen receptor |
| Locus | Xq11-12 |
| Function | Nuclear receptor, transcription factor |
| Length | ~919 aa (isoforms vary) |
Androgen receptor is a steroid hormone receptor and transcription factor that mediates the cellular effects of androgens such as testosterone and dihydrotestosterone. It plays central roles in male sexual differentiation, reproductive physiology, and cellular growth control across tissues including prostate and muscle. The receptor is tightly regulated at genetic, epigenetic, and post‑translational levels and is a major target in oncology and endocrinology.
The gene encoding the receptor is located on the X chromosome and was characterized during positional cloning efforts that involved institutions such as Harvard University, Cold Spring Harbor Laboratory, and National Institutes of Health. Structural studies combining crystallography at facilities like European Synchrotron Radiation Facility and cryo‑EM at Max Planck Institute defined a modular architecture: an N‑terminal transactivation domain, a central DNA‑binding domain with zinc‑finger motifs, a hinge region, and a C‑terminal ligand‑binding domain. Alternative splicing and variable polymorphic trinucleotide repeats in the gene were identified in cohorts from Mayo Clinic, Mount Sinai Health System, and Johns Hopkins Hospital, which influence receptor function. Evolutionary comparisons with nuclear receptors characterized in work from Stanford University and University of Cambridge reveal conserved motifs shared with receptors studied in Yale University and Columbia University research programs.
Ligand binding by the receptor triggers conformational shifts elucidated in studies led by teams at University of California, San Francisco and Massachusetts Institute of Technology, promoting dissociation of chaperones such as heat shock proteins characterized in biochemical research at University of Oxford and University of Toronto. Activated receptor translocates to the nucleus and binds specific androgen response elements characterized in genomics projects at Broad Institute and Wellcome Sanger Institute, recruiting coactivators and corepressors mapped in proteomics studies at European Molecular Biology Laboratory and Max Planck Institute for Biochemistry. Chromatin immunoprecipitation sequencing datasets from University of Pennsylvania and Karolinska Institute demonstrate receptor occupancy at enhancers regulating genes implicated in cell cycle control found in databases curated by National Center for Biotechnology Information and European Bioinformatics Institute.
Receptor expression patterns were profiled in atlases created by Human Protein Atlas and consortia including ENCODE Project and stem cell studies at Howard Hughes Medical Institute. Tissue‑specific regulation involves promoter elements and methylation changes reported by groups at University College London and University of Heidelberg, while microRNA interactions were uncovered in collaborations with Cold Spring Harbor Laboratory and Dana‑Farber Cancer Institute. Post‑translational modifications such as phosphorylation, acetylation, and ubiquitination were characterized in experiments from Salk Institute and Rockefeller University, implicating signaling pathways studied at The Scripps Research Institute and Imperial College London.
The receptor mediates developmental programs studied in clinical centers including Cleveland Clinic and Royal London Hospital, influencing male genitalia formation described in classical texts from Johns Hopkins Hospital School of Medicine. In reproductive biology, receptor signaling coordinates spermatogenesis investigated at Cornell University and University of Michigan. Muscle mass maintenance and metabolism effects were examined in trials at Stanford University Medical Center and Karolinska University Hospital. Neurobehavioral and cognitive roles were explored in cohorts at University of California, Los Angeles and Columbia University Medical Center, with endocrine interactions also reported from studies at Mayo Clinic and Brigham and Women's Hospital.
Mutations, deletions, and expansions in receptor coding or regulatory regions underlie conditions reported by clinics including Great Ormond Street Hospital, Sheffield Teaching Hospitals, and Royal Children's Hospital. Loss‑of‑function variants cause disorders of sexual development documented in case series from University College London Hospitals and Hospital for Sick Children (Toronto), whereas gain‑of‑function alterations and splice variants drive prostate cancer progression extensively characterized by investigators at Dana‑Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, and Johns Hopkins Hospital. Receptor polymorphisms correlate with risks studied in epidemiological cohorts from Framingham Heart Study and international consortia involving World Health Organization collaborators. Resistance mechanisms in castration‑resistant prostate cancer were elucidated in translational programs at MD Anderson Cancer Center and Vall d'Hebron Institute of Oncology.
Therapeutic modulation includes antagonists, agonists, and degraders developed by pharmaceutical companies such as Pfizer, AstraZeneca, GlaxoSmithKline, and biotech firms spun out from Biogen. Antiandrogens like nonsteroidal compounds were advanced through clinical trials at sites including Mayo Clinic and Royal Marsden Hospital, while next‑generation inhibitors and PROTAC degraders emerged from collaborations between University of Texas Southwestern Medical Center and industry partners. Drug resistance and combination strategies have been evaluated in multicenter trials coordinated by groups such as European Organisation for Research and Treatment of Cancer and National Cancer Institute cooperative networks.
Key methods include receptor knockout and transgenic models generated at Jackson Laboratory and phenotype repositories at European Mouse Mutant Archive, as well as cell lines established from patients and maintained at American Type Culture Collection and RIKEN BioResource Center. High‑throughput screening platforms at Broad Institute and genomic editing by CRISPR systems developed at Broad Institute and MIT are widely used to dissect receptor function. Structural biology, ChIP‑seq, RNA‑seq, and mass spectrometry workflows from facilities at Cold Spring Harbor Laboratory and European Molecular Biology Laboratory provide molecular detail, while clinical biomarker assays are standardized through laboratory networks including College of American Pathologists and Clinical Laboratory Improvement Amendments programs.
Category:Steroid hormone receptors